Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives
- PMID: 38803433
- PMCID: PMC11129636
- DOI: 10.3389/fphar.2024.1399882
Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives
Abstract
Hepatocellular carcinoma (HCC) has a high morbidity and mortality rate, and the survival rate of HCC patients remains low. Animal medicines have been used as potential therapeutic tools throughout the long history due to their different structures of biologically active substances with high affinity to the human body. Here, we focus on the effects and the mechanism of action of animal-derived natural products against HCC, which were searched in databases encompassing Web of Science, PubMed, Embase, Science Direct, Springer Link, and EBSCO. A total of 24 natural products from 12 animals were summarized. Our study found that these natural products have potent anti-hepatocellular carcinoma effects. The mechanism of action involving apoptosis induction, autophagy induction, anti-proliferation, anti-migration, and anti-drug resistance via phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR), Ras/extracellular signal regulated kinases (ERK)/mitogen-activated protein kinase (MAPK), Wnt/β-catenin, and Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathways. Huachansu injection and sodium cantharidate have been used in clinical applications with good efficacy. We review the potential of animal-derived natural products and their derivatives in the treatment of HCC to date and summarize their application prospect and toxic side effects, hoping to provide a reference for drug development for HCC.
Keywords: animal medicines; animal-derived natural products; anti-hepatocellular carcinoma; mechanisms; natural products.
Copyright © 2024 Liao, Wei, He, He, Ai, Guo, Zhou, Luo, Li, Wen, Zeng and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Abdel-Lateff A., Al-Abd A. M., Alahdal A. M., Alarif W. M., Ayyad S. E., Al-Lihaibi S. S., et al. (2016). Antiproliferative effects of triterpenoidal derivatives, obtained from the marine sponge Siphonochalina sp., on human hepatic and colorectal cancer cells. Z Naturforsch C J. Biosci. 71, 29–35. 10.1515/znc-2015-0160 - DOI - PubMed
-
- Ai-Ping S. (2020). Study on the construction and pharmacokinetics of toad pastry extract long cycle nanoparticle liposomes system. Shandong, China: Shandong University of Traditional Chinese Medicine; 5.
-
- Babaei Z., Namavari G., Khademi F., Koohpeyma F., Rashidi M., Shafiee S. M., et al. (2023). Potential anti-inflammatory and growth inhibitory effect of cyrtopodion scabrum extract on colon cancer; an in vivo study. Asian Pac J. Cancer Prev. 24, 1209–1216. 10.31557/APJCP.2023.24.4.1209 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
